Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study
- PMID: 32410714
- PMCID: PMC7223395
- DOI: 10.1186/s13054-020-02939-x
Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study
Abstract
Background: A COVID-19 outbreak started in Wuhan, China, last December and now has become a global pandemic. The clinical information in caring of critically ill patients with COVID-19 needs to be shared timely, especially under the situations that there is still a largely ongoing spread of COVID-19 in many countries.
Methods: A multicenter prospective observational study investigated all the COVID-19 patients received in 19 ICUs of 16 hospitals in Wuhan, China, over 24 h between 8 AM February 2h and 8 AM February 27, 2020. The demographic information, clinical characteristics, vital signs, complications, laboratory values, and clinical managements of the patients were studied.
Results: A total of 226 patients were included. Their median (interquartile range, IQR) age was 64 (57-70) years, and 139 (61.5%) patients were male. The duration from the date of ICU admission to the study date was 11 (5-17) days, and the duration from onset of symptoms to the study date was 31 (24-36) days. Among all the patients, 155 (68.6%) had at least one coexisting disease, and their sequential organ failure assessment score was 4 (2-8). Organ function damages were found in most of the patients: ARDS in 161 (71.2%) patients, septic shock in 34 (15.0%) patients, acute kidney injury occurred in 57 (25.2%) patients, cardiac injury in 61 (27.0%) patients, and lymphocytopenia in 160 (70.8%) patients. Of all the studied patients, 85 (37.6%) received invasive mechanical ventilation, including 14 (6.2%) treated with extracorporeal membrane oxygenation (ECMO) at the same time, 20 (8.8%) received noninvasive mechanical ventilation, and 24 (10.6%) received continuous renal replacement therapy. By April 9, 2020, 87 (38.5%) patients were deceased and 15 (6.7%) were still in the hospital.
Conclusions: Critically ill patients with COVID-19 are associated with a higher risk of severe complications and need to receive an intensive level of treatments. COVID-19 poses a great strain on critical care resources in hospitals.
Trial registration: Chinese Clinical Trial Registry, ChiCTR2000030164. Registered on February 24, 2020, http://www.chictr.org.cn/edit.aspx?pid=49983&htm=4.
Keywords: COVID-19; Complications; Critically ill patients; Epidemic.
Conflict of interest statement
All the authors state that there are no conflicts of interest related to this study.
Figures
References
-
- Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, TD MH, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–266. doi: 10.1016/j.ijid.2020.01.009. - DOI - PMC - PubMed
-
- Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. JAMA. 2020. 10.1001/jama.2020.0757. - PubMed
-
- WHO. Situation report-55. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed 12 Apr 2020.
-
- National Health Commission of the People’s Republic of China . March 16: daily briefing on novel coronavirus cases in China. 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
